A detailed history of Northern Trust Corp transactions in Dexcom Inc stock. As of the latest transaction made, Northern Trust Corp holds 3,392,392 shares of DXCM stock, worth $259 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,392,392
Previous 3,489,058 2.77%
Holding current value
$259 Million
Previous $396 Million 42.53%
% of portfolio
0.04%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$64.0 - $116.06 $6.19 Million - $11.2 Million
-96,666 Reduced 2.77%
3,392,392 $227 Million
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $2.54 Million - $3.23 Million
22,994 Added 0.66%
3,489,058 $396 Million
Q1 2024

May 14, 2024

SELL
$114.22 - $140.1 $16.7 Million - $20.5 Million
-146,134 Reduced 4.05%
3,466,064 $481 Million
Q4 2023

Feb 13, 2024

SELL
$75.49 - $124.16 $21.5 Million - $35.3 Million
-284,317 Reduced 7.3%
3,612,198 $448 Million
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $7.85 Million - $12.6 Million
91,249 Added 2.4%
3,896,515 $364 Million
Q2 2023

Aug 11, 2023

SELL
$112.47 - $130.98 $13.8 Million - $16.1 Million
-123,009 Reduced 3.13%
3,805,266 $489 Million
Q1 2023

May 15, 2023

SELL
$104.0 - $122.92 $3.75 Million - $4.43 Million
-36,063 Reduced 0.91%
3,928,275 $456 Million
Q4 2022

Feb 13, 2023

SELL
$84.98 - $122.67 $705,758 - $1.02 Million
-8,305 Reduced 0.21%
3,964,338 $449 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $7.28 Million - $8.98 Million
95,369 Added 2.46%
3,972,643 $320 Million
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $194 Million - $380 Million
2,857,138 Added 280.07%
3,877,274 $289 Million
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $24,460 - $33,852
-260 Reduced 0.03%
1,020,136 $522 Million
Q4 2021

Feb 08, 2022

SELL
$129.87 - $162.82 $363,895 - $456,221
-2,802 Reduced 0.27%
1,020,396 $548 Million
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $646,982 - $868,100
6,063 Added 0.6%
1,023,198 $560 Million
Q2 2021

Aug 13, 2021

BUY
$80.99 - $107.93 $277,147 - $369,336
3,422 Added 0.34%
1,017,135 $434 Million
Q1 2021

May 12, 2021

BUY
$84.79 - $104.74 $410,044 - $506,522
4,836 Added 0.48%
1,013,713 $364 Million
Q4 2020

Feb 11, 2021

SELL
$78.0 - $104.5 $1.79 Million - $2.39 Million
-22,914 Reduced 2.22%
1,008,877 $373 Million
Q3 2020

Nov 16, 2020

BUY
$95.51 - $112.95 $1.63 Million - $1.93 Million
17,115 Added 1.69%
1,031,791 $425 Million
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $24.9 Million - $41.8 Million
396,908 Added 64.25%
1,014,676 $411 Million
Q1 2020

May 14, 2020

BUY
$47.79 - $75.63 $1.41 Million - $2.23 Million
29,420 Added 5.0%
617,768 $166 Million
Q4 2019

Feb 14, 2020

SELL
$36.62 - $57.29 $41,710 - $65,253
-1,139 Reduced 0.19%
588,348 $129 Million
Q3 2019

Nov 13, 2019

BUY
$35.53 - $43.8 $1.17 Million - $1.44 Million
32,966 Added 5.92%
589,487 $88 Million
Q2 2019

Aug 13, 2019

BUY
$27.84 - $38.92 $446,999 - $624,899
16,056 Added 2.97%
556,521 $83.4 Million
Q1 2019

May 13, 2019

BUY
$28.07 - $38.18 $368,109 - $500,692
13,114 Added 2.49%
540,465 $64.4 Million
Q4 2018

Feb 12, 2019

BUY
$26.99 - $37.37 $2.55 Million - $3.53 Million
94,499 Added 21.83%
527,351 $63.2 Million
Q3 2018

Nov 14, 2018

SELL
$23.35 - $36.72 $438,863 - $690,152
-18,795 Reduced 4.16%
432,852 $61.9 Million
Q2 2018

Sep 18, 2018

SELL
$17.54 - $25.22 $92,453 - $132,934
-5,271 Reduced 1.15%
451,647 $42.9 Million
Q2 2018

Aug 14, 2018

BUY
$17.54 - $25.22 $419,241 - $602,808
23,902 Added 5.52%
456,918 $43.4 Million
Q1 2018

May 09, 2018

BUY
$13.06 - $18.54 $90,871 - $129,001
6,958 Added 1.63%
433,016 $32.1 Million
Q4 2017

Feb 14, 2018

SELL
$11.12 - $15.38 $869,105 - $1.2 Million
-78,157 Reduced 15.5%
426,058 $24.5 Million
Q3 2017

Nov 13, 2017

BUY
$11.36 - $18.98 $5.73 Million - $9.57 Million
504,215
504,215 $24.7 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.